Orchestra BioMed President, COO Darren Sherman disposes of $95,400 in common shares

• Orchestra BioMed President and COO Darren Sherman sold 15,000 common shares on Oct. 1, 2026 at USD 6.36.
• Directly held stake fell to 1,119,402 shares following the sale.
• Transaction executed under a Rule 10b5-1 plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-113320), on October 02, 2026, and is solely responsible for the information contained therein.